Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth-Reference-Cited by-同舟云学术

Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth

Published:2021-08 Issue:8 Volume:28 Page:1119-1131.e27
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Müller Martin,Gerndt Susanne,Chao Yu-Kai^ORCID,Zisis Themistoklis,Nguyen Ong Nam Phuong,Gerwien Aaron^ORCID,Urban Nicole,Müller Christoph,Gegenfurtner Florian A.,Geisslinger Franz,Ortler Carina,Chen Cheng-Chang^ORCID,Zahler Stefan,Biel Martin,Schaefer Michael,Grimm Christian^ORCID,Bracher Franz,Vollmar Angelika M.,Bartel Karin^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference68 articles.

1. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy;Abdel-Wahab;Pharmacol. Res.,2019

2. Inhibition of cyclin-dependent kinase 5 - a novel strategy to improve sorafenib response in HCC therapy;Ardelt;Hepatology,2018

3. Strategies and synthetic methods directed toward the preparation of libraries of substituted isoquinolines;Awuah;J. Org. Chem.,2010

4. Generation of genomic deletions in mammalian cell lines via CRISPR/Cas9;Bauer;J. Vis. Exp.,2015

5. Tumorigenesis and the angiogenic switch;Bergers;Nat. Rev. Cancer,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis for inhibition of the lysosomal two-pore channel TPC2 by a small molecule antagonist;Structure;2024-08

2. Descending to inhibit: Antagonist-induced downward shift of VSD II in TPC2;Structure;2024-08

3. The ion channels of endomembranes;Physiological Reviews;2024-07-01

4. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy;Autoimmunity Reviews;2024-06

5. Endolysosomal transient receptor potential mucolipins and two-pore channels: implications for cancer immunity;Frontiers in Immunology;2024-05-22